A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem Cells

Stroke remains a significant unmet condition in the USA and throughout the world. To date, only approximately 3% of the population suffering an ischemic stroke benefit from the thrombolytic drug tissue plasminogen activator, largely due to the drug’s narrow therapeutic window. The last decade has wi...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Glover, Loren E., Tajiri, Naoki, Weinbren, Nathan L., Ishikawa, Hiroto, Shinozuka, Kazutaka, Kaneko, Yuji, Watterson, D. Martin, Borlongan, Cesar V.
פורמט: Artigo
שפה:Inglês
יצא לאור: Springer-Verlag 2011
נושאים:
Review Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3284662/
https://ncbi.nlm.nih.gov/pubmed/22389662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12975-011-0127-8
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים